The American Journal of Medicine
Volume 80, Issue 2, Supplement 1 , Pages 3-6 , 14 February 1986

Coronary heart disease and treatment of hypertension some Oslo study data

  • Paul Leren, M.D.

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Dr. Paul Leren, Medical Outpatient Clinic, Ullevaal Hospital, Oslo 4, Norway.
  • ,
  • Anders Helgeland, M.D.

References 

  1. Leren P, Askevold EM, Foss OP, et al.  The Oslo Study. In: Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand. 1975;p. 6–9 (suppl 588)
  2. Helgeland A. Treatment of mild hypertension: a five-year, controlled drug trial. In: The Oslo Study. Am J Med. 69:1980;p. 725–732
  3. Helgeland A, Hjermann I, Leren P, Enger SC, Holme I. High-density lipoprotein cholesterol and antihypertensive drugs: The Oslo Study. Br Med J. 1978;2:403
  4. Leren P, Foss OP, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG. Effect of propranolol and prazosin on blood lipids. In: The Oslo Study. Lancet. II:1980;p. 4–6
  5. Leren P, Foss OP, Helgeland A, Hjermann I, Holme I. Effects of pindolol and hydrochlorothiazide on blood lipids. Clin Trial J. 1981;18:254
  6. Leren P, Eide I, Foss OP, et al.  Antihypertensive drugs and blood lipids. In: The Oslo Study. J Cardiovasc Pharmacol. 4:1982;p. S222–S224 (suppl 2)
  7. Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL. The effect on HDL cholesterol of oxprenolol and atenolol. Scand J Clin Lab Invest. 1982;42:449–453
  8. Helgeland A, Leren P, Foss OP, Hjermann I, Holme I, Lund-Larsen PG. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. Am J Med. 1984;76:802–805
  9. The Australian Therapeutic Trial in Mild Hypertension . Report by the Management Committee. Lancet. 1980;1:1261–1267
  10. Medical Research Council Working Party . MRC trial of treatment of mild hypertension: principal results. Br Med J. 1985;291:97–104
  11. Ames RP, Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension. Am J Med. 1976;61:748–757
  12. Lasser NL, Grandits G, Caggiula AW, et al.  Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Am J Med. 1984;76(suppl 2A):52–66
  13. Day JL, Metcalfe J, Simpson N, Lowenthal L. Adrenergic mechanisms in the control of plasma lipids in man. Am J Med. 1984;76(suppl 2A):94–96
  14. Ames RP, Hill P. Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy. Circulation. 1982;65:899–904

PII: 0002-9343(86)90153-1

The American Journal of Medicine
Volume 80, Issue 2, Supplement 1 , Pages 3-6 , 14 February 1986